临床用药评价公众号评:虽然2023年IDSA GUIDELINES《Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections》很具有临床借鉴意义,但国内仍需要谨慎引荐,毕竟这份指南的很多数据基于...
即《IDSA 2023版抗微生物药物耐药革兰阴性细菌感染治疗指引(IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections)》。我们一起学习! 该文件出版信息:Tamma PD, Aitken SL, Bonomo RA, Mathers AJ,...
23. We suggest not using the following treatments to address diabetes-related foot infections: (a) adjunctive granulocyte colony-stimulating factor treatment or (b) topical antiseptics, silver preparations, honey, bacteriophage therapy, or negative pressure ...